Pregnancy after uterine fibroid embolization
Liu, Y, Zhang, Z, Rinsurongkawong, W, Gay, CM, Le, X, Ning, M, Lewis, J, Rinsurongkawong, V, Lee, JJ, Roth, JA, Swisher, SG , Gandhi, S, Lee, PP, Gibbons, DL, Vaporciyan, AA, Heymach, JV, Zhang, J, Lin, SH
REIMAGINE 2 was a 68-week efficacy and safety phase 3 trial of CagriSema 2.4 mg/2.4 mg and 1 mg/1 mg once-weekly versus semaglutide 2.4 mg, semaglutide 1 mg, cagrilintide 2.4 mg, and placebo in 2,713 adults with type 2 diabetes inadequately controlled with metformin with or without an SGLT2 inhibitor
Lessard LM, Puhl RM
Yurpeak 2.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise